A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era
10.1038/s41598-020-61378-4
Saved in:
Main Authors: | Lim, R.M.H., Chan, N.P.X., Khoo, L.P., Cheng, C.L., Tan, L., Poon, E.Y.L., Somasundaram, N., Farid, M., Tang, T.P.L., Tao, M., Lim, S.T., Chan, J.Y. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
Nature Research
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/198734 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Rituximab treatment for paraneoplastic pemphigus associated with follicular B-cell lymphoma: A case report and review of treatment outcome
by: Waranaree Winayanuwattikun, et al.
Published: (2019) -
Primary nodal follicular lymphoma with spindle cell features: A potential diagnostic pitfall
by: Lim, D.G.-S., et al.
Published: (2012) -
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
by: Kim, S.J., et al.
Published: (2016) -
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma
by: Smedby K.E., et al.
Published: (2018) -
Rituximab-induced Henoch-Schonlein purpura in a patient with mantle cell lymphoma
by: Watcharoot Kanchongkittiphon, et al.
Published: (2020)